- Home
- SGHT vs NECB Comparison
SGHT vs NECB Comparison
Compare SGHT & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- NECB
- Stock Information
- Founded
- SGHT 2011
- NECB 1934
- Country
- SGHT United States
- NECB United States
- Employees
- SGHT N/A
- NECB N/A
- Industry
- SGHT Medical Specialities
- NECB Savings Institutions
- Sector
- SGHT Health Care
- NECB Finance
- Exchange
- SGHT Nasdaq
- NECB Nasdaq
- Market Cap
- SGHT 304.4M
- NECB 332.8M
- IPO Year
- SGHT 2021
- NECB N/A
- Fundamental
- Price
- SGHT $5.62
- NECB $27.75
- Analyst Decision
- SGHT Buy
- NECB
- Analyst Count
- SGHT 6
- NECB 0
- Target Price
- SGHT $7.20
- NECB N/A
- AVG Volume (30 Days)
- SGHT 144.8K
- NECB 112.7K
- Earning Date
- SGHT 11-07-2024
- NECB 10-29-2024
- Dividend Yield
- SGHT N/A
- NECB 0.93%
- EPS Growth
- SGHT N/A
- NECB 42.35
- EPS
- SGHT N/A
- NECB 3.60
- Revenue
- SGHT $79,395,000.00
- NECB $104,328,000.00
- Revenue This Year
- SGHT $3.39
- NECB N/A
- Revenue Next Year
- SGHT $11.43
- NECB $1.76
- P/E Ratio
- SGHT N/A
- NECB $7.76
- Revenue Growth
- SGHT N/A
- NECB 19.32
- 52 Week Low
- SGHT $1.04
- NECB $13.93
- 52 Week High
- SGHT $8.45
- NECB $28.99
- Technical
- Relative Strength Index (RSI)
- SGHT 42.60
- NECB 68.15
- Support Level
- SGHT $5.74
- NECB $27.23
- Resistance Level
- SGHT $6.08
- NECB $28.32
- Average True Range (ATR)
- SGHT 0.31
- NECB 0.94
- MACD
- SGHT -0.00
- NECB 0.12
- Stochastic Oscillator
- SGHT 32.58
- NECB 75.29
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. They conduct their activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.